Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
19/11/2026
|
5-day change | 1st Jan Change | ||
| 38.15 CNY | -0.39% |
|
-4.10% | -16.37% |
| Market Cap | 25.03B 3.75B 3.42B 3.16B 2.86B 5.37B 350B 5.62B 38.24B 15.17B 189B 14.07B 13.78B 600B | P/E 2026 * |
28.5x | P/E 2027 * | 24.8x |
|---|---|---|---|---|---|
| Enterprise Value | 25.03B 3.75B 3.42B 3.16B 2.86B 5.37B 350B 5.62B 38.24B 15.17B 189B 14.07B 13.78B 600B | EV / Sales 2026 * |
5.08x | EV / Sales 2027 * | 4.68x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.39% | ||
| 1 week | -4.10% | ||
| Current month | -5.33% | ||
| 1 month | -6.77% | ||
| 3 months | +7.01% | ||
| 6 months | -11.95% | ||
| Current year | -16.37% |
| 1 week | 37.89 | 39.65 | |
| 1 month | 37.89 | 43.42 | |
| Current year | 33.83 | 48.2 | |
| 1 year | 33.83 | 48.2 | |
| 3 years | 23.4 | 50.97 | |
| 5 years | 17.98 | 56.26 | |
| 10 years | 11.8 | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Chen
CEO | Chief Executive Officer | 56 | 04/09/2026 |
Jian Ma
DFI | Director of Finance/CFO | 42 | - |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Zhou
BRD | Director/Board Member | 56 | 15/05/2019 |
Min Guo
CHM | Chairman | 55 | 06/09/2021 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 10/12/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.39% | -4.10% | -17.97% | +23.54% | 3.77B | ||
| -2.29% | -5.34% | +28.73% | +128.34% | 1,232B | ||
| -2.04% | -5.78% | +31.91% | +78.34% | 656B | ||
| -0.86% | -3.71% | +21.74% | +105.02% | 506B | ||
| -1.04% | -1.80% | +28.69% | +68.01% | 382B | ||
| -3.61% | -9.62% | +39.73% | +30.53% | 340B | ||
| -3.22% | -5.20% | +24.48% | +51.30% | 294B | ||
| -2.51% | -4.49% | -2.15% | +29.67% | 278B | ||
| -1.14% | -6.05% | +28.16% | +65.35% | 240B | ||
| -1.45% | -0.85% | +30.03% | +120.72% | 210B | ||
| Average | -1.86% | -2.45% | +21.33% | +70.08% | 414B | |
| Weighted average by Cap. | -2.04% | -2.67% | +26.89% | +87.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 739M 673M 623M 564M 1.06B 69B 1.11B 7.53B 2.99B 37.28B 2.77B 2.71B 118B | 5.35B 802M 730M 676M 612M 1.15B 74.87B 1.2B 8.17B 3.24B 40.46B 3.01B 2.94B 128B |
| Net income | 1.04B 155M 141M 131M 118M 222M 14.5B 233M 1.58B 628M 7.83B 582M 570M 24.81B | 1.18B 177M 162M 150M 135M 254M 16.57B 266M 1.81B 717M 8.95B 666M 652M 28.36B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/11/26 | CN¥38.15 | -0.39% | 3,495,147 |
| 18/11/26 | CN¥38.30 | -0.91% | 3,610,110 |
| 17/11/26 | CN¥38.65 | -0.80% | 4,365,227 |
| 16/11/26 | CN¥38.96 | -1.74% | 5,481,867 |
| 13/11/26 | CN¥39.65 | -0.33% | 3,825,883 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.15
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
















